Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Farletuzumab |
Trade Name | |
Synonyms | MORAb-003 |
Drug Descriptions |
Farletuzumab (MORab003) is a monoclonal antibody that binds to FolR1, resulting in decreased interaction between FolR1 and Lyn, as well as increased antibody-dependent cytotoxicity and tumor cell lysis (PMID: 26063635, PMID: 30268765). |
DrugClasses | FOLR1-targeted Therapy 24 |
CAS Registry Number | 896723-44-7 |
NCIT ID | C61503 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Farletuzumab | Farletuzumab | 0 | 1 |